文献

J-GLOBAL ID：201702259143813021   整理番号：17A0872407

選択的ペルオキシソーム増殖因子活性化受容体-αモジュレータK-877は,ペルオキシソーム増殖因子活性化受容体α経路を効率的に活性化し,マウス脂質代謝を改善する

Selective peroxisome proliferator-activated receptor-α modulator K-877 efficiently activates the peroxisome proliferator-activated receptor-α pathway and improves lipid metabolism in mice

著者 (19件)： Takei Kenta (Department of Internal Medicine (Endocrinology and Metabolism), Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan) ,  Han Song-iee (Department of Internal Medicine (Endocrinology and Metabolism), Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan) ,  Murayama Yuki (Department of Internal Medicine (Endocrinology and Metabolism), Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan) ,  Satoh Aoi (Department of Internal Medicine (Endocrinology and Metabolism), Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan) ,  Oikawa Fusaka (Department of Internal Medicine (Endocrinology and Metabolism), Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan) ,  Ohno Hiroshi (Department of Internal Medicine (Endocrinology and Metabolism), Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan) ,  Osaki Yoshinori (Department of Internal Medicine (Endocrinology and Metabolism), Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan) ,  Matsuzaka Takashi (Department of Internal Medicine (Endocrinology and Metabolism), Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan) ,  Sekiya Motohiro (Department of Internal Medicine (Endocrinology and Metabolism), Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan) ,  Iwasaki Hitoshi (Department of Internal Medicine (Endocrinology and Metabolism), Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan) ,  Yatoh Shigeru (Department of Internal Medicine (Endocrinology and Metabolism), Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan) ,  Yahagi Naoya (Department of Internal Medicine (Endocrinology and Metabolism), Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan) ,  Suzuki Hiroaki (Department of Internal Medicine (Endocrinology and Metabolism), Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan) ,  Yamada Nobuhiro (Department of Internal Medicine (Endocrinology and Metabolism), Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan) ,  Nakagawa Yoshimi (Department of Internal Medicine (Endocrinology and Metabolism), Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan) ,  Nakagawa Yoshimi (International Institute for Integrative Sleep Medicine (WPI-IIIS), University of Tsukuba, Tsukuba, Ibaraki, Japan) ,  Shimano Hitoshi (Department of Internal Medicine (Endocrinology and Metabolism), Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan) ,  Shimano Hitoshi (International Institute for Integrative Sleep Medicine (WPI-IIIS), University of Tsukuba, Tsukuba, Ibaraki, Japan) ,  Shimano Hitoshi (Life Science Center, Tsukuba Advanced Research Alliance (TARA), University of Tsukuba, Tsukuba, Ibaraki, Japan)
資料名： Journal of Diabetes Investigation (Web)  (Journal of Diabetes Investigation (Web))
巻： 8  号： 4  ページ： 446-452  発行年： 2017年 
JST資料番号： U0507A  ISSN： 2040-1124  資料種別： 逐次刊行物 (A)
記事区分： 原著論文  発行国： アメリカ合衆国 (USA)  言語： 英語 (EN)

抄録/ポイント： 目的/序論:ペルオキシソーム増殖因子活性化受容体α(PPAR...

シソーラス用語： *脂質低下薬 ,...
準シソーラス用語： 遺伝的調節 ,...

ログイン（無料）して見る     続きはJDreamIII（有料）にて  {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=17A0872407&from=J-GLOBAL&jstjournalNo=U0507A") }}

著者キーワード (3件)： Lipid metabolism ,  Peroxisome proliferator-activated receptor-α ,  Selective peroxisome proliferator-activated receptor-α modulator

分類 (1件)： 脂質代謝作用薬の基礎研究  (GW13040M)

物質索引 (3件)： Wy-14643 ,  フェノフィブラート ,  K-877

引用文献 (17件)：

• Ip E, Farrell GC, Robertson G, et al. Central role of PPARalpha-dependent hepatic lipid turnover in dietary steatohepatitis in mice. Hepatology 2003; 38: 123-132.
• Diabetes Atherosclerosis Intervention Study Investigators. Effect of fenofibrate on progression of coronary-artery disease in type 2 diabetes: the Diabetes Atherosclerosis Intervention Study, a randomised study. Lancet 2001; 357: 905-910.
• Bloomfield Rubins H, Davenport J, Babikian V, et al. Reduction in stroke with gemfibrozil in men with coronary heart disease and low HDL cholesterol: the Veterans Affairs HDL Intervention Trial (VA-HIT). Circulation 2001; 103: 2828-2833.
• Rubins HB, Robins SJ, Collins D, et al. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans affairs high-density lipoprotein cholesterol intervention trial study group. N Engl J Med 1999; 341: 410-418.
• Tanne D, Koren-Morag N, Graff E, et al. Blood lipids and first-ever ischemic stroke/transient ischemic attack in the Bezafibrate Infarction Prevention (BIP) Registry: high triglycerides constitute an independent risk factor. Circulation 2001; 104: 2892-2897.

タイトルに関連する用語 (7件)： ペルオキシソーム増殖因子活性化受容体 ,  モジュレータ ,  K-877 ,  経路 ,  活性化 ,  マウス ,  脂質代謝